Imatinib tablets 100mg “KMP,” manufactured by Kyoso Mirai Pharma (YJ code: 4291011F1206, standard: 100mg 1 tablet), contain imatinib mesylate, an oral tyrosine kinase inhibitor for managing and treating chronic myelogenous leukemia and other malignancies.
Imatinib tablets 100mg “KMP”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
